Company Overview

Update
Founded:
2008
Headquarters:
Salt Lake City, UT
Funding:
$44.6M
Categories:
Biotechnology
Description:
Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia and other pregnancy complications.

Detailed Description

Update

Sera Prognostics is a private biotechnology company developing diagnostic tests that use proprietary biomarkers that are predictive of preterm birth and other pregnancy complications. Sera was founded in 2008 and licensed its serum proteomics discovery technology and novel peptides from Brigham Young University and the University of Utah. The company has assembled a board of directors and management team with significant clinical development and women’s healthcare diagnostic experience for translating scientific innovation into commercial products that help patients and build significant corporate value. Sera is located in Salt Lake City, Utah.

Current Team (3)

Update

Past Team (1)

Update

Funding Rounds (5) - $44.6M

Update

Board Members and Advisors (2)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    417 Wakara Way

    Suite 3510

    Salt Lake City, UT 84108

    USA